Connect with us
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
In the race for a reliable vaccine against the new coronavirus, five companies from the international biotech sector have become the focus of investors in recent...